Clinical trial
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients…
NCT00185133 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00185133 |
|---|---|
| Title | Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension |
| Official title | A Randomized, Double-blind, Placebo-controlled Factorial Study Evaluating the Efficacy and Safety of Co-administration of Olmesartan Medoxomil Plus Amlodipine Compared to Monotherapy in Patients With Mild to Severe Hypertension |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Olmesartan medoxomil, Amlodipine |
| Enrollment | 1,900 |
| Start date | May 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Dec 24, 2018 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: